Dyrness Albert D.

Director at Hyperliquid Strategies Inc · on record since Dec 23, 2025
Director at Outlook Therapeutics, Inc. · on record since May 12, 2016
Director at Sonnet BioTherapeutics Holdings, Inc. · on record since Jun 12, 2020

Insider trading activity of Dyrness Albert D.

Transactions on record: 14; since Dec 27, 2016

Open-market buys: 2; $20.6K

Open-market sells: 0

Companies traded: 3; last filing Feb 11, 2026

Figures computed from official regulatory filings — .

Companies where Dyrness Albert D. has traded

Hyperliquid Strategies Inc2 tx · Feb 11, 2026
Sonnet BioTherapeutics Holdings, Inc.10 tx · $20.6K · Dec 3, 2025
Outlook Therapeutics, Inc.2 tx · Oct 30, 2017

Track record of Dyrness Albert D.

Insufficient history for a statistical track record (fewer than 5 open-market buys).

Transaction history of Dyrness Albert D.

Co-insiders of Dyrness Albert D.

Bhatt NaileshHyperliquid Strategies Inc +1
Griffith Donald J.Outlook Therapeutics, Inc. +1
MCANDREW STEPHEN JOutlook Therapeutics, Inc. +1
Mohan PankajOutlook Therapeutics, Inc. +1
ADAMS RICHARDSonnet BioTherapeutics Holdings, Inc.
Albrecht ClaudioOutlook Therapeutics, Inc.
Auffarth GerdOutlook Therapeutics, Inc.
Bahrt KennethOutlook Therapeutics, Inc.
Bao KoganOutlook Therapeutics, Inc.
Beldner Brett DouglasHyperliquid Strategies Inc
BLOCK WILLIAM ASonnet BioTherapeutics Holdings, Inc.
Brady Todd COutlook Therapeutics, Inc.
Canute Scott AOutlook Therapeutics, Inc.
Carroll J MichaelSonnet BioTherapeutics Holdings, Inc.
Cini John K.Sonnet BioTherapeutics Holdings, Inc.
CORBMAN BRIANSonnet BioTherapeutics Holdings, Inc.
Cross John Harry IIISonnet BioTherapeutics Holdings, Inc.
Dagnon TerryOutlook Therapeutics, Inc.

This page republishes public regulatory disclosures.

Company	Filed	Type	Qty	Price	Value · USD	Signals	Src
Hyperliquid Strategies IncListing unverified	Feb 11, 2026	Award	40,789	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Hyperliquid Strategies IncListing unverified	Dec 23, 2025	Other	882	—	n/a (No price was disclosed in the filing)		SEC
Sonnet BioTherapeutics Holdings, Inc.Listing unverified	Dec 3, 2025	Other	-4,537	—	n/a (No price was disclosed in the filing)		SEC
Sonnet BioTherapeutics Holdings, Inc.Listing unverified	Jul 15, 2025	Award	4,000	—	n/a (No price was disclosed in the filing)		SEC
Sonnet BioTherapeutics Holdings, Inc.Listing unverified	Dec 5, 2024	Award	373	—	n/a (No price was disclosed in the filing)		SEC
Sonnet BioTherapeutics Holdings, Inc.Listing unverified	May 31, 2023	Buy	23,255	0.47 USD	$10.9K	conv 89ClusterFirst in 12mo	SEC
Sonnet BioTherapeutics Holdings, Inc.Listing unverified	Dec 22, 2022	Award	3,770	—	n/a (No price was disclosed in the filing)		SEC
Sonnet BioTherapeutics Holdings, Inc.Listing unverified	Apr 8, 2022	Award	14,152	—	n/a (No price was disclosed in the filing)		SEC
Sonnet BioTherapeutics Holdings, Inc.Listing unverified	Jul 2, 2020	Award	8,005	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Sonnet BioTherapeutics Holdings, Inc.Listing unverified	Jun 12, 2020	Buy	2,409	4.01 USD	$9.7K	conv 81ClusterFirst in 12mo	SEC
Sonnet BioTherapeutics Holdings, Inc.Listing unverified	Apr 3, 2020	AwardD (derivative)	1,279	—	n/a (No price was disclosed in the filing)		SEC
Sonnet BioTherapeutics Holdings, Inc.Listing unverified	Apr 3, 2020	Award	2,557	—	n/a (No price was disclosed in the filing)		SEC
Outlook Therapeutics, Inc.Listing on record	Oct 30, 2017	AwardD (derivative)	15,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Outlook Therapeutics, Inc.Listing on record	Dec 27, 2016	BuyD (derivative)	11,500	—	n/a (No price was disclosed in the filing)	First in 12mo	SEC

Company	Filed	Type	Qty	Price	Value · USD	Signals	Src
Hyperliquid Strategies IncListing unverified	Feb 11, 2026	Award	40,789	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Hyperliquid Strategies IncListing unverified	Dec 23, 2025	Other	882	—	n/a (No price was disclosed in the filing)		SEC
Sonnet BioTherapeutics Holdings, Inc.Listing unverified	Dec 3, 2025	Other	-4,537	—	n/a (No price was disclosed in the filing)		SEC
Sonnet BioTherapeutics Holdings, Inc.Listing unverified	Jul 15, 2025	Award	4,000	—	n/a (No price was disclosed in the filing)		SEC
Sonnet BioTherapeutics Holdings, Inc.Listing unverified	Dec 5, 2024	Award	373	—	n/a (No price was disclosed in the filing)		SEC
Sonnet BioTherapeutics Holdings, Inc.Listing unverified	May 31, 2023	Buy	23,255	0.47 USD	$10.9K	conv 89ClusterFirst in 12mo	SEC
Sonnet BioTherapeutics Holdings, Inc.Listing unverified	Dec 22, 2022	Award	3,770	—	n/a (No price was disclosed in the filing)		SEC
Sonnet BioTherapeutics Holdings, Inc.Listing unverified	Apr 8, 2022	Award	14,152	—	n/a (No price was disclosed in the filing)		SEC
Sonnet BioTherapeutics Holdings, Inc.Listing unverified	Jul 2, 2020	Award	8,005	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Sonnet BioTherapeutics Holdings, Inc.Listing unverified	Jun 12, 2020	Buy	2,409	4.01 USD	$9.7K	conv 81ClusterFirst in 12mo	SEC
Sonnet BioTherapeutics Holdings, Inc.Listing unverified	Apr 3, 2020	AwardD (derivative)	1,279	—	n/a (No price was disclosed in the filing)		SEC
Sonnet BioTherapeutics Holdings, Inc.Listing unverified	Apr 3, 2020	Award	2,557	—	n/a (No price was disclosed in the filing)		SEC
Outlook Therapeutics, Inc.Listing on record	Oct 30, 2017	AwardD (derivative)	15,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Outlook Therapeutics, Inc.Listing on record	Dec 27, 2016	BuyD (derivative)	11,500	—	n/a (No price was disclosed in the filing)	First in 12mo	SEC